TTrialPathMatch Me to Trials
← Back to trials
RecruitingCoronary Artery Disease

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

Eligible age

18+ yrs

Accepts

All genders

Locations

9 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

Sponsor: Emory University

You may qualify if…

  • ✓ All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB

You may not qualify if…

  • ✕ Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions

Where it's recruiting

Arizona

Phoenix

Florida

Fort Lauderdale

Georgia

Atlanta · Johns Creek

Minnesota

Minneapolis

New York

New York · Roslyn

North Carolina

Charlotte · Durham

Ohio

Cleveland

Tennessee

Nashville

Source: ClinicalTrials.gov · NCT07559903 · last updated 2026-10-05

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revasculariz · TrialPath